ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Transplantation for Hepatocellularcarcinoma Is There a Tumor Size Limit?

A. Daoud, L. Teeter, M. Ghobrial, E. Graviss, S. Mogawer, A. Sholkamy, M. Alshazly, H. Monsour, A. Gaber.

Houston Methodist Hospital, Houston, TX
Cairo University Medical School, Cairo, Egypt
University of Arkansas for Medical Sciences, Little Rock, AR.

Meeting: 2016 American Transplant Congress

Abstract number: A184

Keywords: Hepatocellular carcinoma

Session Information

Session Name: Poster Session A: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies

Session Type: Poster Session

Date: Saturday, June 11, 2016

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Halls C&D

Background:The advent of tumor size based criteria (Milan and UCSF) for transplantation of Hepatocellular carcinomas (HCC) has facilitated access of tumor patients to transplantation. Recent success in transplanting patients with larger tumors (beyond UCSF) necessitates understanding of patient, tumor and biological criteria that determine successful outcome for HCC Transplantation across all size criteria.

Methods: We analyzed 11,928 patients who received OLT from 2002 till 2013 from the UNOS star file. Clinical outcomes were compared by tumor size at transplant; Milan (N=11555), beyond Milan within UCSF (N=291) & beyond both Milan & UCSF (N=82). Statistical analysis was done to determine factors impacting survival.

Results: There were no statistically significant differences in the 1, 3, and 5 year Survival {Fig 1} between the three patient groups (within Milan 91.1%, 74.8%, 60.3%, beyond Milan within UCSF 92.7%, 71.1%, 51.6%, beyond both Milan & UCSF 95.8%, 75.9%, and 58.1%. In multivariate analysis the hazard ratio and 95% CI of factors significantly affecting survival included, AA race (1.56; 1.37-1.78), AFP >3000 (2.41; 1.77-3.28), Hepatitis C infection (1.45; 1.30-1.62) with age, diabetes and largest tumors diameter having a more modest impact. Total tumor burden and time to transplantation were not significant predictors of survival. Multivariate analysis within Milan only patients demonstrated stability of the hazard ratios for race, hepatitis C infection, tumor diameter, age and diabetes.

Conclusions: These data indicate that based on current clinical selection criteria a small number of large tumors can be successfully treated by transplantation, and points to the need to include markers of HCC biologic behavior beyond size and tumor burden to transplant criteria.

CITATION INFORMATION: Daoud A, Teeter L, Ghobrial M, Graviss E, Mogawer S, Sholkamy A, Alshazly M, Monsour H, Gaber A. Transplantation for Hepatocellularcarcinoma Is There a Tumor Size Limit? Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Daoud A, Teeter L, Ghobrial M, Graviss E, Mogawer S, Sholkamy A, Alshazly M, Monsour H, Gaber A. Transplantation for Hepatocellularcarcinoma Is There a Tumor Size Limit? [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/transplantation-for-hepatocellularcarcinoma-is-there-a-tumor-size-limit/. Accessed May 9, 2025.

« Back to 2016 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences